Comments
Avigo Capital Partners, a private equity fund, announced a share subscription of 9.27 per cent equity stake through its Mauritius investment arm, Avigo PE Investments Ltd (Mauritius), in Super Religare Laboratories Ltd (SRL) for an aggregate amount of Rs 100 crore at Rs 134.85 a share, based on the number of shares post issue (7,99,98,989, according to the DRHP).
This constitutes a pre-IPO placement; Super Religare's draft red herring prospectus with SEBI in February this year provides for a placement of up to 80 lakh shares, or 10 per cent of the post-issue paid up capital.
As on December 31, 2010, SRL had a network of eight reference laboratories, seven ‘Centres of Excellence', 181 network laboratories, 15 wellness centres and 888 collection centres.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.